1. Home
  2. XNCR vs HOV Comparison

XNCR vs HOV Comparison

Compare XNCR & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • HOV
  • Stock Information
  • Founded
  • XNCR 1997
  • HOV 1959
  • Country
  • XNCR United States
  • HOV United States
  • Employees
  • XNCR N/A
  • HOV N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • HOV Homebuilding
  • Sector
  • XNCR Health Care
  • HOV Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • HOV Nasdaq
  • Market Cap
  • XNCR 1.1B
  • HOV 877.2M
  • IPO Year
  • XNCR 2013
  • HOV N/A
  • Fundamental
  • Price
  • XNCR $13.86
  • HOV $121.03
  • Analyst Decision
  • XNCR Buy
  • HOV Hold
  • Analyst Count
  • XNCR 11
  • HOV 1
  • Target Price
  • XNCR $23.50
  • HOV $120.00
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • HOV 95.4K
  • Earning Date
  • XNCR 11-05-2025
  • HOV 12-04-2025
  • Dividend Yield
  • XNCR N/A
  • HOV N/A
  • EPS Growth
  • XNCR N/A
  • HOV N/A
  • EPS
  • XNCR N/A
  • HOV 20.64
  • Revenue
  • XNCR $150,132,000.00
  • HOV $3,140,315,000.00
  • Revenue This Year
  • XNCR $22.09
  • HOV N/A
  • Revenue Next Year
  • XNCR N/A
  • HOV $6.78
  • P/E Ratio
  • XNCR N/A
  • HOV $5.86
  • Revenue Growth
  • XNCR 38.16
  • HOV 7.83
  • 52 Week Low
  • XNCR $6.92
  • HOV $81.15
  • 52 Week High
  • XNCR $27.24
  • HOV $202.00
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 54.01
  • HOV 40.70
  • Support Level
  • XNCR $13.30
  • HOV $117.86
  • Resistance Level
  • XNCR $15.16
  • HOV $126.10
  • Average True Range (ATR)
  • XNCR 1.14
  • HOV 5.31
  • MACD
  • XNCR -0.18
  • HOV -0.45
  • Stochastic Oscillator
  • XNCR 50.22
  • HOV 16.88

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

Share on Social Networks: